Oxford Drug Design

Overview

At Oxford Drug Design we leverage our knowledge of tRNA synthetases (aaRS) and generative AI methods to rapidly advance multiple drug candidates to the clinic – promising new therapies designed to treat major diseases where this enzyme family plays a key role.

We focus on identifying novel disease targets based on the non-canonical functions of aaRS and integrate this new biochemistry with our pioneering computational platform trained specifically on this target family.

Blue Boar Court
9 Alfred Street
Oxford OX1 4EH, UK

contactus@oxforddrugdesign.com
+44 (0)1865 261468

Quick Links
© Oxford Drug Design. All Rights Reserved 2023. Legal Information. Site Design by Koma.live